Tetsuya Kodama
Overview
Explore the profile of Tetsuya Kodama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
124
Citations
1149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kodama T, Sukhbaatar A
Expert Opin Drug Deliv
. 2025 Feb;
PMID: 39995110
Introduction: The low drug delivery rate of systemic chemotherapyto metastatic lymph nodes (LNs) may be due to tumor growth without tumorneovascularization in the LNs, loss of existing blood vessels and...
2.
Suzuki T, Sato T, Sukhbaatar A, Sakamoto M, Mori S, Kodama T, et al.
J Cancer
. 2025 Jan;
16(2):368-381.
PMID: 39744489
Intravesical instillation of chemotherapy has been performed to reduce the risk of intravesical recurrence of bladder cancer. However, its antitumor effect is not necessarily sufficient, which may be partially due...
3.
Takagi K, Sukhbaatar A, Inaba Y, Mori S, Kodama T
Cancer Sci
. 2024 Oct;
115(12):4021-4033.
PMID: 39380185
The combination of radiotherapy and immunotherapy is a promising approach that has been shown in clinical trials to improve significantly survival and response rates compared with monotherapy against solid tumor....
4.
Sukhbaatar A, Mori S, Sugiura T, Kodama T
Biomed Pharmacother
. 2024 Jan;
171:116085.
PMID: 38171241
Recently, sentinel lymph nodes (LNs) have been recognized as a starting point of hematogenous metastasis; thus, an increase in the control rate of LN metastasis is expected to improve the...
5.
Olorundare F, Sipuka D, Sebokolodi T, Kodama T, Arotiba O, Nkosi D
Anal Methods
. 2023 Jul;
15(29):3577-3585.
PMID: 37458385
The early detection of cancer is a key step in cancer survival. Thus, there is a need to develop low-cost technologies, such as electrochemical immunosensor technologies, for timely screening and...
6.
Sukhbaatar A, Mori S, Shiga K, Kodama T
Biomed Pharmacother
. 2023 Jul;
165:115110.
PMID: 37421779
Lymph node metastasis (LNM) has a significant impact on cancer prognosis, emphasizing the need for effective treatment strategies. This study investigated the potential use of high osmotic pressure drug solutions...
7.
Mishra R, Sukhbaatar A, Mori S, Kodama T
J Exp Clin Cancer Res
. 2023 May;
42(1):132.
PMID: 37259163
Background: Immune checkpoint blockade (ICB) elicits a strong and durable therapeutic response, but its application is limited by disparate responses and its associated immune-related adverse events (irAEs). Previously, in a...
8.
Mishra R, Sukhbaatar A, Dorai A, Mori S, Shiga K, Kodama T
Cancer Sci
. 2022 Sep;
114(1):259-270.
PMID: 36168838
Treatment of metastatic lymph nodes (LNs) is challenging due to their unique architecture and biophysical traits. Systemic chemotherapy fails to impede tumor progression in LNs due to poor drug uptake...
9.
Sora S, Sukhbaatar A, Fukushige S, Mori S, Sakamoto M, Kodama T
Cancer Sci
. 2022 Sep;
114(1):227-235.
PMID: 36056924
Chemotherapy using a lymphatic drug delivery system (LDDS) targeting lymph nodes (LNs) in the early stage of metastasis has a superior antitumor effect to systemic chemotherapy. An LDDS produces a...
10.
Sukhbaatar A, Kodama T
Methods Mol Biol
. 2022 Jul;
2524:333-346.
PMID: 35821485
Bioluminescence (BL) imaging is a powerful non-invasive imaging modality widely used in a broad range of biological disciplines for many types of measurements. The applications of BL imaging in biomedicine...